These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 30470740)
1. Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap. Lee YA; Noon LA; Akat KM; Ybanez MD; Lee TF; Berres ML; Fujiwara N; Goossens N; Chou HI; Parvin-Nejad FP; Khambu B; Kramer EGM; Gordon R; Pfleger C; Germain D; John GR; Campbell KN; Yue Z; Yin XM; Cuervo AM; Czaja MJ; Fiel MI; Hoshida Y; Friedman SL Nat Commun; 2018 Nov; 9(1):4962. PubMed ID: 30470740 [TBL] [Abstract][Full Text] [Related]
2. High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis. Chen R; Zhu S; Fan XG; Wang H; Lotze MT; Zeh HJ; Billiar TR; Kang R; Tang D Hepatology; 2018 May; 67(5):1823-1841. PubMed ID: 29149457 [TBL] [Abstract][Full Text] [Related]
3. Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis. Liu Y; Zhuo S; Zhou Y; Ma L; Sun Z; Wu X; Wang XW; Gao B; Yang Y J Hepatol; 2022 Mar; 76(3):652-664. PubMed ID: 34793870 [TBL] [Abstract][Full Text] [Related]
4. YAP activation is an early event and a potential therapeutic target in liver cancer development. Perra A; Kowalik MA; Ghiso E; Ledda-Columbano GM; Di Tommaso L; Angioni MM; Raschioni C; Testore E; Roncalli M; Giordano S; Columbano A J Hepatol; 2014 Nov; 61(5):1088-96. PubMed ID: 25010260 [TBL] [Abstract][Full Text] [Related]
5. Role of YAP Activation in Nuclear Receptor CAR-Mediated Proliferation of Mouse Hepatocytes. Abe T; Amaike Y; Shizu R; Takahashi M; Kano M; Hosaka T; Sasaki T; Kodama S; Matsuzawa A; Yoshinari K Toxicol Sci; 2018 Oct; 165(2):408-419. PubMed ID: 29893953 [TBL] [Abstract][Full Text] [Related]
6. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation. Cheng JC; Wang EY; Yi Y; Thakur A; Tsai SH; Hoodless PA Mol Cancer Res; 2018 Oct; 16(10):1543-1555. PubMed ID: 29903770 [TBL] [Abstract][Full Text] [Related]
7. Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer. Xiao W; Wang J; Ou C; Zhang Y; Ma L; Weng W; Pan Q; Sun F Biochem Biophys Res Commun; 2013 Sep; 439(2):167-72. PubMed ID: 23994632 [TBL] [Abstract][Full Text] [Related]
8. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells. Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935 [TBL] [Abstract][Full Text] [Related]
9. Two-signal requirement for growth-promoting function of Yap in hepatocytes. Su T; Bondar T; Zhou X; Zhang C; He H; Medzhitov R Elife; 2015 Feb; 4():. PubMed ID: 25667983 [TBL] [Abstract][Full Text] [Related]
10. Targeting YAP and Hippo signaling pathway in liver cancer. Liu AM; Xu MZ; Chen J; Poon RT; Luk JM Expert Opin Ther Targets; 2010 Aug; 14(8):855-68. PubMed ID: 20545481 [TBL] [Abstract][Full Text] [Related]
11. Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer. Kim Y; Jho EH BMB Rep; 2017 Jun; 50(6):281-282. PubMed ID: 28502290 [TBL] [Abstract][Full Text] [Related]
12. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Yi C; Shen Z; Stemmer-Rachamimov A; Dawany N; Troutman S; Showe LC; Liu Q; Shimono A; Sudol M; Holmgren L; Stanger BZ; Kissil JL Sci Signal; 2013 Sep; 6(291):ra77. PubMed ID: 24003254 [TBL] [Abstract][Full Text] [Related]